UBS Group
INBS icon

UBS Group’s Intelligent Bio Solutions INBS Stock Holding History

UBS Group’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.2K Buy
5,735
+5,363
+1,442% +$14.1K ﹤0.01% 8407
2026
Q1 		$1.24K Sell
372
-3,682
-91% -$25.4K ﹤0.01% 9575
2025
Q4 		$38.6K Buy
+4,054
New +$33K ﹤0.01% 7361
2025
Q3 		– Sell
-30
Closed -$516 – 10587
2025
Q2 		$516 Sell
30
-87
-74% -$1.25K ﹤0.01% 9807
2025
Q1 		$1.69K Sell
117
-173
-60% -$3.23K ﹤0.01% 9464
2024
Q4 		$4.06K Buy
290
+135
+87% +$2.06K ﹤0.01% 8793
2024
Q3 		$2.68K Sell
155
-677
-81% -$10.6K ﹤0.01% 8389
2024
Q2 		$16K Buy
832
+797
+2,277% +$20.4K ﹤0.01% 7451
2024
Q1 		$1.47K Buy
+35
New +$1.45K ﹤0.01% 8125
2023
Q2 		– Sell
-5
Closed -$1.78K – 9237
2023
Q1 		$1.78K Buy
5
+1
+25% +$918 ﹤0.01% 8648
2022
Q4 		$2.15K Buy
+4
New +$3.84K ﹤0.01% 9726
2022
Q3 		– Sell
-5
Closed -$7.58K – 10611
2022
Q2 		$8K Hold
5
– – ﹤0.01% 8313
2022
Q1 		$9K Buy
5
+1
+25% +$2.3K ﹤0.01% 8550
2021
Q4 		$13K Buy
4
+1
+33% +$4.59K ﹤0.01% 8454
2021
Q3 		$16K Buy
+3
New +$23K ﹤0.01% 7418
2021
Q2 		– Sell
-1
Closed -$9K – 9572
2021
Q1 		$9K Buy
+1
New +$17.2K ﹤0.01% 8005
2020
Q4 		– Hold
0
– – – 7624

Other funds holding INBS

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

UBS Group's INBS Position: Q2 2026 in Review

UBS Group increased its Intelligent Bio Solutions (INBS) stake by 1,442% in Q2 2026, buying an estimated $14.1K and bringing the position to 5,735 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #8407.

UBS Group first reported a position in INBS in Q1 2021 and has held it in 16 quarters since. The position peaked at $38.6K in Q4 2025. 8 funds tracked by Wall St. Rank hold INBS as of Q2 2026.

  • UBS Group held 5,735 shares of Intelligent Bio Solutions worth $13.2K as of Q2 2026.
  • UBS Group bought 5,363 Intelligent Bio Solutions shares in Q2 2026, an estimated $14.1K.
  • Intelligent Bio Solutions made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8407 holding.
  • UBS Group first reported a position in Intelligent Bio Solutions in Q1 2021 and has held it in 16 quarters since.
  • UBS Group's Intelligent Bio Solutions position peaked at $38.6K in Q4 2025.
  • 8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.